{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:52:35Z","timestamp":1779879155463,"version":"3.53.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05040-5","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:18:30Z","timestamp":1748665110000},"page":"6214-6224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Investigation of transient severe motion artifacts on gadoxetic acid\u2013enhanced MRI: frequency and risk factors"],"prefix":"10.1007","volume":"50","author":[{"given":"Yuttapol","family":"Hirun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wittanee Na Chiang","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwalee","family":"Pojchamarnwiputh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5667-9986","authenticated-orcid":false,"given":"Nakarin","family":"Inmutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"issue":"1","key":"5040_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/RLI.0000000000000806","volume":"57","author":"DW Kim","year":"2022","unstructured":"Kim DW, Choi SH, Park T, Kim SY, Lee SS, Byun JH. Transient Severe Motion Artifact on Arterial Phase in Gadoxetic Acid\u2013Enhanced Liver Magnetic Resonance Imaging: A Systematic Review and Meta-analysis. Invest Radiol. 2022;57(1):62\u201370.","journal-title":"Invest Radiol"},{"issue":"2","key":"5040_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.11101742","volume":"262","author":"L Grazioli","year":"2012","unstructured":"Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid\u2013enhanced MR imaging in differential diagnosis. Radiology. 2012;262(2):520\u20139.","journal-title":"Radiology"},{"issue":"2","key":"5040_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1148\/radiol.12112677","volume":"266","author":"T Hyodo","year":"2013","unstructured":"Hyodo T, Murakami T, Imai Y, Okada M, Hori M, Kagawa Y, et al. Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma. Radiology. 2013;266(2):480\u201390.","journal-title":"Radiology"},{"issue":"2","key":"5040_CR4","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1148\/radiol.12120826","volume":"266","author":"MS Davenport","year":"2013","unstructured":"Davenport MS, Viglianti BL, Al-Hawary MM, Caoili EM, Kaza RK, Liu PS, et al. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology. 2013;266(2):452\u201361.","journal-title":"Radiology"},{"issue":"3","key":"5040_CR5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1007\/s00330-017-5070-y","volume":"28","author":"JS Song","year":"2018","unstructured":"Song JS, Choi EJ, Park EH, Lee JH. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method. Eur Radiol. 2018;28(3):1132\u20139.","journal-title":"Eur Radiol"},{"issue":"12","key":"5040_CR6","doi-asserted-by":"publisher","first-page":"6694","DOI":"10.1007\/s00330-020-07039-6","volume":"30","author":"J Rimola","year":"2020","unstructured":"Rimola J, Darnell A, Belmonte E, Sapena V, Caparroz C, Llarch N, et al. Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid. Eur Radiol. 2020;30(12):6694\u2013701.","journal-title":"Eur Radiol"},{"issue":"1","key":"5040_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1148\/radiol.2015150642","volume":"279","author":"U Motosugi","year":"2016","unstructured":"Motosugi U, Bannas P, Bookwalter CA, Sano K, Reeder SB. An Investigation of Transient Severe Motion Related to Gadoxetic Acid\u2013enhanced MR Imaging. Radiology. 2016;279(1):93\u2013102.","journal-title":"Radiology"},{"issue":"2","key":"5040_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1148\/radiol.2016160482","volume":"282","author":"TR McClellan","year":"2017","unstructured":"McClellan TR, Motosugi U, Middleton MS, Allen BC, Jaffe TA, Miller CM, et al. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial. Radiology. 2017;282(2):361\u20138.","journal-title":"Radiology"},{"issue":"2","key":"5040_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2214\/AJR.16.16860","volume":"208","author":"MS Davenport","year":"2017","unstructured":"Davenport MS, Malyarenko DI, Pang Y, Hussain HK, Chenevert TL. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis. AJR Am J Roentgenol. 2017;208(2):328\u201336.","journal-title":"AJR Am J Roentgenol"},{"key":"5040_CR10","doi-asserted-by":"crossref","unstructured":"Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radiology. 2018;289(3):816\u201330.","DOI":"10.1148\/radiol.2018181494"},{"issue":"12","key":"5040_CR11","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.1007\/s00330-022-08885-2","volume":"32","author":"EB Jang","year":"2022","unstructured":"Jang EB, Kim DW, Choi SH, Hong SB, Park T, Ko Y, et al. Transient severe motion artifacts on gadoxetic acid\u2013enhanced MRI: risk factor analysis in 2230 patients. Eur Radiol. 2022;32(12):8629\u201338.","journal-title":"Eur Radiol"},{"issue":"6","key":"5040_CR12","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2214\/AJR.14.13677","volume":"204","author":"SY Kim","year":"2015","unstructured":"Kim SY, Park SH, Wu EH, Wang ZJ, Hope TA, Chang WC, et al. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses. AJR Am J Roentgenol. 2015;204(6):1220\u20137.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"5040_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1148\/radiol.14140386","volume":"274","author":"MR Bashir","year":"2015","unstructured":"Bashir MR, Castelli P, Davenport MS, Larson D, Marin D, Hussain HK, et al. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Radiology. 2015;274(1):141\u20138.","journal-title":"Radiology"},{"issue":"4","key":"5040_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2214\/AJR.13.11587","volume":"203","author":"MS Davenport","year":"2014","unstructured":"Davenport MS, Bashir MR, Pietryga JA, Weber JT, Khalatbari S, Hussain HK. Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. AJR Am J Roentgenol. 2014;203(4):796\u2013802.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"5040_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.crad.2016.08.005","volume":"72","author":"A Furlan","year":"2017","unstructured":"Furlan A, Close ON, Borhani AA, Wu YH, Heller MT. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients. Clin Radiol. 2017;72(1):93.e1-.e6.","journal-title":"Clin Radiol"},{"key":"5040_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mri.2018.06.022","volume":"53","author":"A Kanki","year":"2018","unstructured":"Kanki A, Tamada T, Abe T, Ikenaga H, Yoshida K, Ito K. Relationship between transient severe motion of the liver in gadoxetic acid or iodinated contrast agent-enhanced imaging and arterial oxygen saturation and heart rate changes. Magn Reson Imaging. 2018;53:77\u201381.","journal-title":"Magn Reson Imaging"},{"issue":"7","key":"5040_CR17","doi-asserted-by":"publisher","first-page":"e0200887","DOI":"10.1371\/journal.pone.0200887","volume":"13","author":"KI Ringe","year":"2018","unstructured":"Ringe KI, von Falck C, Raatschen HJ, Wacker F, Hinrichs J. Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI-Influence of different contrast agent application protocols. PLoS One. 2018;13(7):e0200887.","journal-title":"PLoS One"},{"key":"5040_CR18","doi-asserted-by":"publisher","first-page":"109313","DOI":"10.1016\/j.ejrad.2020.109313","volume":"132","author":"N Vietti Violi","year":"2020","unstructured":"Vietti Violi N, Argiriadi P, Rosen A, Cherny M, Weiss A, Hernandez-Meza G, et al. Gadoxetate disodium-enhanced MRI: Assessment of arterial phase artifacts and hepatobiliary uptake in a large series. Eur J Radiol. 2020;132:109313.","journal-title":"Eur J Radiol"},{"issue":"7","key":"5040_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1055\/s-0043-102940","volume":"189","author":"L Well","year":"2017","unstructured":"Well L, Rausch VH, Adam G, Henes FO, Bannas P. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution. Rofo. 2017;189(7):651\u201360.","journal-title":"Rofo"},{"issue":"3","key":"5040_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1148\/radiol.2015141646","volume":"276","author":"T Hayashi","year":"2015","unstructured":"Hayashi T, Saitoh S, Tsuji Y, Takahashi J, Tagaya N, Hiramoto M, et al. Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR Imaging. Radiology. 2015;276(3):756\u201365.","journal-title":"Radiology"},{"issue":"2","key":"5040_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1148\/radiol.13131988","volume":"271","author":"JA Pietryga","year":"2014","unstructured":"Pietryga JA, Burke LM, Marin D, Jaffe TA, Bashir MR. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition. Radiology. 2014;271(2):426\u201334.","journal-title":"Radiology"},{"issue":"1","key":"5040_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1148\/radiol.14132269","volume":"272","author":"MS Davenport","year":"2014","unstructured":"Davenport MS, Caoili EM, Kaza RK, Hussain HK. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine. Radiology. 2014;272(1):123\u201331.","journal-title":"Radiology"},{"issue":"1","key":"5040_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0043-120116","volume":"190","author":"L Well","year":"2018","unstructured":"Well L, Weinrich JM, Adam G, Bannas P. Transient Severe Respiratory Motion Artifacts After Application of Gadoxetate Disodium: What We Currently Know. Rofo. 2018;190(1):20\u201330.","journal-title":"Rofo"},{"issue":"3","key":"5040_CR24","doi-asserted-by":"publisher","first-page":"e0265588","DOI":"10.1371\/journal.pone.0265588","volume":"17","author":"T Sugiura","year":"2022","unstructured":"Sugiura T, Okumura K, Sasaki M, Matsumoto J, Ogi T, Yoneda N, et al. A low albumin level as a risk factor for transient severe motion artifact induced by gadoxetate disodium administration: A retrospective observational study with free-breathing dynamic MRI and an experimental study in rats. PLoS One. 2022;17(3):e0265588.","journal-title":"PLoS One"},{"key":"5040_CR25","volume-title":"T. All about Albumin: Biochemistry, Genetics, and Medical Applications","author":"Peters Jr","year":"1995","unstructured":"Peters Jr. T. All about Albumin: Biochemistry, Genetics, and Medical Applications.: Academic Press, Cambridge; 1995."},{"issue":"2","key":"5040_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jhep.2012.01.031","volume":"57","author":"BE Van Beers","year":"2012","unstructured":"Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect? J Hepatol. 2012;57(2):421\u20139.","journal-title":"J Hepatol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05040-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:07:49Z","timestamp":1762880869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05040-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5040"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05040-5","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}